Shanghai Medicilon (SHSE:688202) EPS (Basic): ¥-1.04 (TTM As of Mar. 2026)

What is Shanghai Medicilon EPS (Basic)?

Shanghai Medicilon SHSE:688202 -1.29% 73 EPS (Basic) is ¥-1.04 as of Mar. 2026. GuruFocus rates SHSE:688202 with a GF Score™ of 73/100 and a GF Value™ of ¥46.13 (Significantly Overvalued). The stock has 4 warning signs investors should review.

Shanghai Medicilon's basic earnings per share (Basic EPS) for the three months ended in Mar. 2026 was ¥0.12. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was ¥-1.04.

Shanghai Medicilon's EPS (Diluted) for the three months ended in Mar. 2026 was ¥0.12. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was ¥-1.04.

Shanghai Medicilon's EPS without NRI for the three months ended in Mar. 2026 was ¥0.13. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was -0.53.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 12 years, Shanghai Medicilon's highest 3-Year average EPS without NRI Growth Rate was 50.10% per year. The lowest was 10.70% per year. And the median was 31.30% per year.

Shanghai Medicilon (SHSE:688202) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Shanghai Medicilon EPS (Basic) Related Terms

Shanghai Medicilon EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Shanghai Medicilon's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Medicilon EPS (Basic) Chart

Shanghai Medicilon Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

EPS (Basic)

Get a 7-Day Free Trial

2.32

2.78

-0.26

-2.47

-1.27

Shanghai Medicilon Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
EPS (Basic)	Get a 7-Day Free Trial															-0.11	0.01	-0.12	-1.05	0.12

73GF Score

Shanghai Medicilon Inc SHSE:688202

EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Shanghai Medicilon EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Shanghai Medicilon's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-167.828	-	0)	/	132.148
	=	-1.27

Shanghai Medicilon's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(15.615	-	0)	/	130.128
	=	0.12

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-1.04

Frequently Asked Questions Learn more about EPS (Basic) →

What does a EPS (Basic) of ¥-1.04 mean?

Shanghai Medicilon (SHSE:688202) has a EPS (Basic) of ¥-1.04 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Shanghai Medicilon and its competitors.

Is Shanghai Medicilon's EPS (Basic) too high?

Shanghai Medicilon's current EPS (Basic) is ¥-1.04. Overall, Shanghai Medicilon has a GF Score™ of 73/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.

How does Shanghai Medicilon's EPS (Basic) compare to VRTX and REGN?

Shanghai Medicilon's EPS (Basic) of ¥-1.04 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good EPS (Basic) for a Biotechnology company?

A good EPS (Basic) depends on the Biotechnology industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high EPS (Basic) mean?

A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Shanghai Medicilon and its competitors. Shanghai Medicilon's current EPS (Basic) is ¥-1.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Shanghai Medicilon stock overvalued right now?

Based on GuruFocus' analysis, Shanghai Medicilon (SHSE:688202) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥46.13, compared to a current price of ¥70.57 — trading 53% above its estimated fair value. The current EPS (Basic) is ¥-1.04. Shanghai Medicilon's overall GF Score™ is 73/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is EPS (Basic) calculated?

EPS (Basic) is calculated from a company's financial statements. For Shanghai Medicilon (SHSE:688202), the current EPS (Basic) is ¥-1.04 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shanghai Medicilon (SHSE:688202) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai Medicilon stock appears to be overvalued. The current stock price of ¥70.57 is trading 53% above its estimated GF Value™ of ¥46.13. GuruFocus considers Shanghai Medicilon to be Significantly Overvalued.

Key valuation signals for SHSE:688202:

EPS (Basic): ¥-1.04
GF Value™: ¥46.13 vs. price of ¥70.57 (53% above fair value)
GF Score™: 73/100 with 4 warning signs

No single metric tells the full story. See the SHSE:688202 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shanghai Medicilon Business Description

Industry Healthcare Biotechnology

Comparable Companies SHSE:688068 SHSE:605116 SHSE:688177 SHSE:688658 SHSE:688253 SHSE:603229 SHSE:688046 SZSE:301047 SZSE:300497 SHSE:688105 VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY RVMD ASX:CSL ONC XKRX:068270

Address Lane 67, Libing Road, Building 5, Pilot Free Trade Zone, Shanghai, CHN, 201299

Website http://www.medicilon.com.cn

Shanghai Medicilon Inc is a comprehensive biomedical research and developemnt service company. It provides a full range of one-stop new drug development services for pharmaceutical companies and research institutions around the world in line with domestic and international reporting standards.

73GF Score

Get the complete analysis for SHSE:688202

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥70.57

Price

¥46.13

GF Value

View SHSE:688202 Analysis

See EPS (Basic) data for all stocks →